Asset Management One’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Asset Management One’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-42,086	Closed	-$4.74M	–	1056
2017 Q3	$4.74M	Buy	42,086 +6,738	+19%	+$733K	0.01%	772
2017 Q2	$3.96M	Hold	35,348	–	–	0.01%	737
2017 Q1	$4.12M	Buy	35,348 +11,703	+49%	+$1.3M	0.01%	722
2016 Q4	$2.49M	Buy	23,645 +23,465	+13,036%	+$2.46M	0.01%	749
2016 Q3	$20K	Sell	180 -10,173	-98%	-$1.35M	﹤0.01%	1304
2016 Q2	$1.51M	Buy	10,353 +1,583	+18%	+$224K	0.02%	716
2016 Q1	$1.26M	Buy	+8,770	New	+$1.25M	0.02%	796

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Asset Management One's TARO Position: Q4 2017 in Review

Asset Management One sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 42,086 shares — an estimated $4.74M sold.

Asset Management One first reported a position in TARO in Q1 2016 and held it in 7 quarters. The position peaked at $4.74M in Q3 2017. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Asset Management One reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Asset Management One sold 42,086 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $4.74M.
Asset Management One first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 7 quarters.
Asset Management One's Taro Pharmaceutical Industries Ltd. position peaked at $4.74M in Q3 2017.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Asset Management One's 13F filing for Q4 2017, filed 14 Feb 2018.